Clorox Balance Sheet Health
Financial Health criteria checks 2/6
Clorox has a total shareholder equity of $138.0M and total debt of $2.7B, which brings its debt-to-equity ratio to 1958.7%. Its total assets and total liabilities are $5.5B and $5.4B respectively. Clorox's EBIT is $1.0B making its interest coverage ratio 12.3. It has cash and short-term investments of $166.0M.
Key information
1,958.70%
Debt to equity ratio
US$2.70b
Debt
| Interest coverage ratio | 12.3x |
| Cash | US$166.00m |
| Equity | US$138.00m |
| Total liabilities | US$5.39b |
| Total assets | US$5.53b |
Recent financial health updates
Recent updates
Here's Why Shareholders May Want To Be Cautious With Increasing The Clorox Company's (NYSE:CLX) CEO Pay Packet
Nov 12
Clorox (NYSE:CLX) Strong Profits May Be Masking Some Underlying Issues
Nov 10Clorox Q1: There Are Concerns Beyond Transitory ERP Weakness
Nov 04Clorox (NYSE:CLX) Has Announced That It Will Be Increasing Its Dividend To $1.24
Aug 04Earnings Beat: The Clorox Company Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models
Aug 02Returns On Capital At Clorox (NYSE:CLX) Have Stalled
Jul 16Why Investors Shouldn't Be Surprised By The Clorox Company's (NYSE:CLX) P/E
Apr 24Slowing Rates Of Return At Clorox (NYSE:CLX) Leave Little Room For Excitement
Apr 06Clorox: Reviving From Cyberattack; Initiate With 'Buy'
Mar 29Clorox: A Wonderful Business I Would Like To Own At A Lower Price
Feb 27An Intrinsic Calculation For The Clorox Company (NYSE:CLX) Suggests It's 37% Undervalued
Feb 25The Clorox Company Just Recorded A 24% EPS Beat: Here's What Analysts Are Forecasting Next
Feb 06The Price Is Right For The Clorox Company (NYSE:CLX)
Jan 15We Think Clorox (NYSE:CLX) Can Manage Its Debt With Ease
Dec 24Return Trends At Clorox (NYSE:CLX) Aren't Appealing
Dec 02The Clorox Company: Hold, Trading Above Fair Value Despite Positive Signals
Nov 26Clorox: If You Need FMCG Player In A Portfolio - Look Elsewhere
Sep 15Clorox: Stellar Delivery But Valuation Compression Has Some Distance To Go
Jul 29Clorox: Questionable Growth Target Puts Me On The Sidelines
Jul 17Clorox: Improving Outlook, Good Dividend Yield And Discounted Valuation
Jun 28Colgate-Palmolive: Improved Financials To Navigate Headwinds (Rating Upgrade)
Apr 21Clorox: Relatively Overvalued And Headwinds Put Dividend At Risk
Feb 08Financial Position Analysis
Short Term Liabilities: CLX's short term assets ($1.7B) do not cover its short term liabilities ($2.2B).
Long Term Liabilities: CLX's short term assets ($1.7B) do not cover its long term liabilities ($3.2B).
Debt to Equity History and Analysis
Debt Level: CLX's net debt to equity ratio (1838.4%) is considered high.
Reducing Debt: CLX's debt to equity ratio has increased from 212.1% to 1958.7% over the past 5 years.
Debt Coverage: CLX's debt is well covered by operating cash flow (31.6%).
Interest Coverage: CLX's interest payments on its debt are well covered by EBIT (12.3x coverage).
Balance Sheet
Discover healthy companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/11/19 12:42 |
| End of Day Share Price | 2025/11/19 00:00 |
| Earnings | 2025/09/30 |
| Annual Earnings | 2025/06/30 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
The Clorox Company is covered by 35 analysts. 17 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| John Staszak | Argus Research Company |
| Lauren Lieberman | Barclays |
| Lauren Lieberman | Barclays |